Acute Ischemic Stroke Diagnosis and Treatment Market Market Size, Share, Development, Growth and Demand Forecast to 2020

GLOBAL INDUSTRY INSIGHT:
Acute Ischemic Stroke Diagnosis and Treatment Market Size, Share,
Development, Growth and Demand Forecast to 2020

Global «Keyword» Market Size, Share, Development, Growth and
Demand Forecast to 2020
Acute ischemic stroke refers to a sudden loss of certain brain function owing to uneven or lack of blood to the
brain. Acute ischemic functions are mainly triggered by atherosclerosis plaques blocking blood vessels, blood
clots locking the blood distribution to or from arteries nourishing the brain, or narrowing of blood vessels of the
brain. Acute ischemic stroke is one of the major causes of permanent disability in the patients. It is also the third
largest reason of death worldwide. Acute ischemic stroke can affect persons of all age groups. However, acute
ischemic stroke most commonly affects the individuals, who are above 60 years, the risk of acute ischemic stroke
increases with age. Driven by the technical advancement in diagnosis, the acute ischemic stroke diagnosis and
treatment demand is expected to experience an escalating demand in coming years.
To know more visit: https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-andtreatment-market
The advancements in the surgical devices technology, in addition with the rising occurrence of acute ischemia
stroke cases among the patients are some of the dominant driving factor for the surgery in acute stroke treatment.
Some of the other factors driving the market include, aging population mainly in the developed countries of
Europe and North America. The development of the effective medication in the treatment of ischemic stroke is
accepted to hinder the acceptance of expensive surgery in the ischemic stroke diagnosis market. The
development of desmoteplase, a novel next-generation thrombolytic, is one of the major advancement of in the
treatment technology of acute ischemic stroke. It provides extended therapeutic time compared to most of the
other treatment procedure. Moreover, with the increasing impact of telemedicine and e-prescription and e-medical
adherence the acute ischemic stroke diagnosis and treatment market is expected to flourish at a healthy rate
during the forecast period.
The major hindrance in the development of acute ischemic stroke diagnosis and treatment market is in the clinical
trial, which include long testing of drug after stroke onset, in addition to insufficient selection of patients for the
trials.
Based on the various diagnosis and treatment the global acute ischemic stroke diagnosis and treatment market
can be segmented as computed tomography, magnetic resonance imaging, ultrasound, cerebral angiography,
nuclear imaging, and others. Based on the various surgery types the global acute ischemic stroke diagnosis and
treatment market can be broadly segmented as carotid endarterectomy, angioplasty, and endovascular
mechanical thrombectomy.
Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=247&title=TOC
© P&S Market Research. All rights reserved 2

Global «Keyword» Market Size, Share, Development, Growth and
Demand Forecast to 2020
According to the American Heart Association, acute ischemic stroke is among the top three causes of death in the
U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014. Out of which 85% of
patients were suffering from ischemic strokes.
North America was the largest market of acute ischemic stroke diagnosis and treatment in 2014. The market
dominance of the North America is attributed to high percentage of patients suffering from strokes, in admiration
with the technical advancement in the treatment procedure acute ischemic stroke in the region. It is then followed
by Europe; the large population of baby boomers in Europe is one of the factors for a high market share in acute
ischemic stroke diagnosis and treatment market. Country wise, the U.S., Canada are two of the major markets in
North America. Germany, Italy, the U.K, and France are some of the dominant market in Europe, Japan, China
and India are the major market of Asia Pacific region.
Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/medical-devices
Some of the leading players operating in global acute ischemic stroke diagnosis and treatment market include,
Abbott Laboratories, Covidien plc, Johnson & Johnson (Cordis Corporation), Penumbra, Inc., Philips Healthcare,
GE Healthcare, Hitachi, Ltd., Siemens Healthcare, and Stryker Corporation (Concentric Medical, Inc.)
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry forecasting reports,
business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through
their interaction with leading companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing informed and customized business
expansion strategies in different regions.
Contact:
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
© P&S Market Research. All rights reserved 3

Global «Keyword» Market Size, Share, Development, Growth and
Demand Forecast to 2020
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
© P&S Market Research. All rights reserved 4